Lasa Supergenerics has announced its 11th Annual General Meeting for September 30, 2026, to be held via video conferencing. Key agenda items include the appointment of Mr. Janardan Savala as Executive Director, a proposal to borrow funds to address a disputed external loan, and new limits for managerial remuneration and charitable donations.
Lasa Supergenerics Announces 11th AGM and Board Reorganization
Lasa Supergenerics has scheduled its 11th Annual General Meeting (AGM) for September 30, 2026, at 9:30 AM via video conferencing. The company is seeking shareholder approval for key governance and financial mandates, including new borrowing powers and board-level appointments.
Reader Takeaway: New executive oversight and borrowing plans to address debt disputes highlight significant governance and financial shifts.
What just happened
Lasa Supergenerics has released the notice for its upcoming AGM. Shareholders will vote on the appointment of Mr. Janardan Savala as Executive Director for a five-year term starting August 26, 2026. Additionally, the company seeks to re-appoint Mr. Omkar Herlekar to the board. The company will also appoint Shivam Sharma & Associates as secretarial auditors for the period spanning FY 2026 to FY 2030.
Why this matters
The filing includes a specific proposal for the Board to borrow funds beyond its current capital and reserves, with proceeds intended to settle an alleged and disputed external loan. This highlights an ongoing legal or financial complexity that shareholders must weigh. Additionally, the company is seeking approval for managerial remuneration of up to Rs 3 crore per annum, even in years where the company may report inadequate or no profits.
Governance and Donations
Shareholders are being asked to authorize annual charitable donations of up to Rs 2 crore, including contributions to the Dr. Omkar Herlekar Foundation. This resolution seeks approval to exceed standard limits relative to the company’s net profits, granting the board greater flexibility in its philanthropic outflows.
Risks to watch
The primary risk area is the disputed debt. The company’s stated intent to utilize newly approved borrowing powers to address this specifically mentioned "alleged" loan suggests a potential drag on future cash flows or the necessity of further leverage. Investors should scrutinize the disclosure regarding the nature of this dispute during the AGM.
What to track next
The closure of the Register of Members and Share Transfer Books from September 23, 2026, to September 29, 2026, will determine voting eligibility. Shareholders should monitor the e-voting process and potential disclosures during the AGM regarding the resolution of the disputed debt and the strategy of the newly appointed Executive Director.